course directorsStéphan Haulon, lille, france

Tim ReSCh, malmö, sweden

steering committee for critical issues

Eric VErhoEVEn, Martin Malina, John BrEnnan & richard McWilliaMs

limited seats

2012

fina

l pr

ogra

m

16th international experts symposium

CritiCal issuesin aortic endografting 2012w w w . c r i t i c a l - i s s u e s - c o n g r e s s . c o m

May 24 & 25lille - france

6 credits 9 credits

Emmanuel aBaTE, Buc, France

Donald aDaM, Birmingham, United Kingdom

Jean-Pierre BECQUEMin, Créteil, France

John BrEnnan, Liverpool, United Kingdom

Peter BUnGaY, Derby, United Kingdom

Piergiorgio Cao, Rome, Italy

Tom CarrEll, London, United Kingdom

nick ChEshirE, London, United Kingdom

roberto ChiEsa, Milan, Italy

Tim ChUTEr, San Francisco, USA

rachel CloUGh, London, United Kingdom

Marc CoGGia, Boulogne, France

Michael DakE, Stanford, USA

Ghislaine DEklUnDEr, Lille, France

Jean-Paul DE VriEs, Nieuwegein, The Netherlands

Eric DUCassE, Bordeaux, France

Marcelo FErrEira, Rio de Janeiro, Brazil

Martin FUnoViCs, Vienna, Austria

Marc GianoTTi, Redwood City, USA

richard GiBBs London, United Kingdom

George haMilTon, London, United Kingdom

reda hassEn-khoDJa, Nice, France

stéphan haUlon, Lille, France

andrew holDEn, Auckland, New Zealand

krassi iVanCEV, London, United Kingdom

Michael JaCoBs, Maastricht, The Netherlands

Piotr kasPrZak, Regensburg, Germany

Tilo kÖlBEl, Hamburg, Germany

ralph kolVEnBaCh,

Düsseldorf, Germany

Mohamed koUssa, Lille, France

Mario laChaT, Zurich, Switzerland

anthony lEE, Bocaraton, USA

Martin Malina, Malmö, Sweden

Blandine MaUrEl, Lille, France

richard McWilliaMs, Liverpool, United Kingdom

Marco MiDUlla, Lille, France

Christoph niEnaBEr, Rostock, Germany

Michael nilson, Flagstaff, USA

alain PraT, Lille, France

Giovanni PraTEsi, Florence, Italy

Thierry rEiX, Amiens, France

Martine rEMY-JarDin, Lille, France

Tim rEsCh, Malmö, Sweden

Vincent riaMBaU, Barcelona, Spain

Blayne roEDEr, Bloomington, USA

Uta rossECk, Karlsruhe, Germany

Jonathan soBoCinski, Lille, France

Björn sonEsson, Malmö, Sweden

Eric sTEinMETZ, Dijon, France

Peter TaYlor, London, United Kingdom

Jörg TEssarEk, Münster, Germany

Matt ThoMPson, London, United Kingdom

Frank VEiTh, New York, USA

hence VErhaGEn, Rotterdam, The Netherlands

Eric VErhoEVEn, Nuremberg, Germany

Frank VErMassEn, Gent, Belgium

Fabio VErZini, Perugia, Italy

Willem WissElink, Amsterdam, The Netherlands

faCu

ltY GE Healthcare

Complex procedures do not require complex solutions. You want a hybrid solution that brings high defi nition vascular imaging and fl exibility in an environment you can be comfortable with. When you know the time is right to expand, advance and improve the care you give, trust a leader in vascular imaging technology.

Merging capabilities. Expanding opportunities. The New Hybrid OR. Learn more at gehealthcare.com/euen/surgery/minimally_invasive_hybrid_OR.html

© 2012 General Electric Company.

GE imagination at work

thursdaY MaY 24

7.45 Welcoming coffee

8.00 thoraCiC aorta Chairmen: S. Haulon, T. Chuter part 1: acute type b dissections

late results from the insTEaD trial, C. Nienaber Update on the aDsorB trial, E. Verhoeven are aortic bare stents needed?, J. Sobocinski GorE side branch endograft, M. Dake Predicting type B aortic dissection outcomes with computational flow

analysis, R. Gibbs Dissection aortic devices, B. Roeder PaNel deBate: Do we need to change the current treatment guidelines in

the treatment of acute uncomplicated type B dissection?

8.50 part 2: unresolved thoracic aorta issues

The celiac trunk should never be covered: current experience with the BolTon MEDiCal scalloped endograft, V. Riambau

Endovascular treatment of mycotic thoracic aneurysms: bridge or definitive option?, P. Taylor

Mixed evidence regarding coverage of the lsa, H. Verhagen retrograde ascending hematoma, M. Dake

PaNel deBate

9.30 iMagiNg Chairmen: T. Resch, R. McWilliams

new CT protocols to lower radiation dose and contrast media volume before and after aortic endografting, M. Remy-Jardin

Fusion imaging: development of a new software, T. Carrell Evaluation of new endografts: can Mri predict failure?, R. Clough Mobile or fixed imaging systems to perform aortic endografting?, S. Haulon Fusion imaging, 3D rotational angiography or Co2 for standard and

complex aortic endografting, K. Ivancev EVar follow-up with Ultra-sound, G. Deklunder PaNel deBate: Should we modify the current eVaR follow-up

recommendations?

10.30 Break on the exhibition hall

LOWERPROFILE,† HYDROPHILIC DELIVERY SYSTEM FOR ENHANCED ACCESS

LONGER LIMB LENGTHS OFFER MULTIPLE OPTIONS TO IMPROVE EASE OF USE

IMPROVED RADIOPACITY FOR INCREASED VISIBILITY TO AID IN GATE CANNULATION‡

**Patients treated with Endurant AAA Stent Graft System†28mm aortic stent graft‡Gate cannulation marker

For more information, please visit medtronicendovascular.com

More than

56,000patients treated

worldwide with Endurant in 3.5 years*

UC201201568EE © Medtronic, Inc. 2012. All Rights Reserved.

Projet3_Delavega 02/05/12 14:06 Page1

thursdaY MaY 24

11.00 Para reNal aNeurYsMs, PatieNts seleCtioN Chairmen: G. Hamilton, P. Cao

Which patients should not have para renal aneurysms open repair?, E. Steinmetz

Which patients should not have para renal aneurysms laparoscopic repair?, M. Coggia

When can chimneys work?, M. Malina Fenestrated endografts: causes of long term failure, J. Brennan Can the EnDoloGiX nellix repair all para renal aneurysms?, A. Holden results from the French multicentric fenestrated trial: can we predict

outcomes?, J-P. Becquemin PaNel deBate: Which treatment for which patient?

12.00 Para reNal aNeurYsMs, teChNiCal asPeCts Chairmen: P. Taylor, M. Ferreira

secondary procedures after aortic aneurysm repair with fenestrated and branched endografts, J. Tessarek

VasCUTEk fenestrated endograft: current indications and limitations, P. Bungay

EnDoloGiX Ventana off-the-shelf fenestrated endograft: current indications and limitations, A. Holden Cook MEDiCal off-the-shelf fenestrated endograft: current indications and limitations, T. Resch

MEDTroniC abdominal branched endograft: current indications and limitations, W. Wisselink

PaNel deBate: Which endograft for which anatomy?

13.00 lunch on the exhibition hall

14.00 thoraCoaBdoMiNal aNeurYsMs part 1 Chairmen: E. Verhoeven, F. Veith

open or endovascular repair?, P. Cao hybrid repair of thoracoabdominal aortic aneurysms: state of the art, R. Chiesa

Methods of preventing spinal cord ischaemia during Taa open and endovascular surgery, J-P. de Vries

Update on the “sac perfusion branch” to prevent spinal cord ischaemia, K. Ivancev

Endovascular repair: how to minimize post operative risk, T. Resch PaNel deBate: Should only high volume centers perform these procedures?

14.45 thoraCoaBdoMiNal aNeurYsMs part 2 Chairmen: M. Jacobs, B. Sonesson

Pre loaded branched and fenestrated endografts, P. Kasprzak The configuration of sidebranches is important to match anatomy, M. Ferreira “off the shelf” branched endograft: patient selection and sizing, T. Chuter repair of recurrent visceral aortic patch aneurysm after open

thoracoabdominal aortic aneurysm repair, D. Adam Chronic type B dissections: are fenestrated and branched endografts an

option?, S. Haulon PaNel deBate: What are the current contra indications for Taaa

endovascular repair?

15.30 Break on the exhibition hall

16.00 NeW teChNologies - NeW aortiC eNdografts aNd BridgiNg steNts

Chairmen: V. Riambau, K. Ivancev robotic endovascular catheters for arch vessel cannulation, N. Cheshire new generation aTriUM MEDiCal stentgraft, E. Verhoeven CorDis abdominal endograft, G. Pratesi Cook MEDiCal purpose build bridging stents, B. Roeder MEDTroniC next generation abdominal endograft, P. Cao Dissection cutting catheter, M. Nilson new aBBoTT VasCUlar stentgraft projects, M. Gianotti The new generation BarD stent graft for sFa disease, U. Rosseck

Clinical trial results of Treovance, the latest generation of aaa stentgraft, R. Chiesa

PaNel deBate: “new” is “better”? assessment of durability and clinical utility?

17.30 The next generation of hybrid or systems from GE healthcare, E. Abate

18.00 ge cocktail on the exhibition hall

20.30 official dinner

fridaY MaY 25

11.30 asCeNdiNg aorta Chairmen: M. Thompson, A. Prat

What is the best method for precise endograft implantation: rapid pacing, iVC occlusion, drugs?, C. Nienaber

Type a dissections: anatomical studies, J. Sobocinski ascending aorta endografting, R. Kolvenbach Visceral fenestration prior to ascending aorta open repair in acute type a

dissections, M. Midulla Transseptal and transapical antegrade access for TEVar, T. Kölbel ascending aorta endografting: the BolTon MEDiCal experience,

M. Funovics PaNel deBate: Is it time for prospective randomized trial versus open

repair?

12.30 adjournment

w w w . c r i t i c a l - i s s u e s - c o n g r e s s . c o m

8.00 Welcoming coffee

8.15 aBdoMiNal aorta Chairmen: M. Malina, T. Reix

Does EVar suitability impact outcomes of aaa and raaa repair, F. Veith improved results with 3rd generation endografts, F. Verzini Percutaneous closure devices: technique and literature review,

R. Hassen-Khodja Endovascular repair of aorto-enteric fistula: a bridge to surgery?, F. Vermassen Endovascular repair of aortic aneurysms under local anaesthesia, M. Lachat aortic bifurcation occlusive disease: are covered stents an alternative?,

P. Kasprzak PaNel deBate

9.20 iNterNal iliaC BraNCh Chairmen: A. Holden, E. Ducasse

internal iliac occlusion is safe during EVar, F. Veith internal iliac occlusion is unnecessary during EVar, E. Verhoeven Tips and tricks for branched iliac, G. Pratesi Preliminary experience with the bifurcated iliac device, B. Roeder PaNel deBate: Is buttock claudication an issue?

10.00 Break on the exhibition hall

10.30 arCh Chairmen: M. Koussa, S. Haulon MEDTroniC branched endograft, M. Thompson open and hybrid techniques, B. Maurel BolTon MEDiCal branched endograft, A. Lee in-situ fenestrations, B. Sonesson Cook MEDiCal branched endograft, T. Chuter PaNel deBate: Which technique for which patient?

Congress venueWorld Trade Center / Crowne Plaza lille - euralille335 Bd de leeds - lille, 59777 - France Tel. +33 (0)3 20 42 46 46 - Fax. +33 (0)3 20 40 13 14www.lille-crowneplaza.com

Facing the TGV train station, very close to the old city of lille.

Train station: TGV / Eurostar: lille Europe or lille Flandres

airport: lille – lesquin (10km)

road: a1 highway. Follow «lille centre», exit «Gare lille Europe»

Hotel day parking card: 20e (reservation mandatory)

registration fees before march 12 after & onsite

Physicians or exhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . 370€ . . . . . . . . . . . . . . 470€

residents, fellows, nurses & technicians . . . . . . . . . . 200€ . . . . . . . . . . . . . . 250€ (a confirmation letter will be asked)

The registration fees include: access to all scientific Medical sessions, access to exhibition hall, welcoming coffees, coffee breaks & the lunch only on Thursday May 24.

hotel accommodationincluding breakfast, city tax not included single double

➊ congress venue: crowne Plaza Lille**** 175,00€ . . . . . . . . . . 175,00€

335 Bd de leeds➋ carlton Lille Hotel**** . . . . . . . . . . . . . . . . . . . .200,00€ . . . . . . . . . . 200,00€

3, rue de Paris (15 mn walk)➌ Hôtel Up**** . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .199,00€ . . . . . . . . . . 228,00€

17 place des reignaux (10 mn walk)➍ Lille europe Hotel** . . . . . . . . . . . . . . . . . . . . . . .107,50€ . . . . . . . . . . 116,00€

av. le Corbusier (6 mn walk)

Cancellation before april 20: refund less 10% (administrative charge). Cancellation after april 20: no refund will be given. name changes will be accepted before May 11. no-shows at the congress will be charged the full fee. refund will be processed until end of september 2012.one night deposit needed to confirm any hotel booking. The whole stay has to be paid before april 20 to avoid cancellation of reservation. City tax is not included.

Parc desDondaines

SquareAugustinLaurent

Musée desBeaux-Arts

de Lille

Gare deLille-Europe

Place del’Europe

L’Aéronef

Gare deLille-Flandres

Gare deLille-Flandres

Rihour

Mairiede Lille

République desBeaux-Arts

Notre Damede la Treille

VIEUX LILLE Parc HenriMatisse

Aéroport deLille-Lesquin

D651

D941

D14Rue de Luxembourg

Bd de TurinBd Louis Pasteur

Bd Louis Pasteur

Rue Eugène Jacquet

Rue des Canonniers

Rue de la Monnaie

Av. du Peuple Belge

Rue de TournaiRue Javary

Bd Emile D

ubuisson

Av. du Président Kennedy

Rue de Paris

Rue de ParisRue du Molinel

Rue Nationale

Bd C

arno

t

Rue Basse

Rue

Rue d

es To

urs

Saint-Jacques

Rue

Thie

rs

Office deTourisme et desCongrès de Lille

Bd de la Liberté

Av. le Corbusie

r

ROUBAIXTOURCOING

A1 / PARISA16 / VALENCIENNESA25 / DUNKERQUEA26 / REIMSA27 / BRUXELLES

Opérade Lille

Grand Place

fullybooked

fullybookedfully

booked

register online at www.critical-issues-congress.com

official dinnerThursday May 24 (20.30)➎ “au bout des doigts” restaurantregistration mandatory at the registration desk Contribution to costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20€ per person

R E L A Y T h o r a c i c S t e n t - G r a f tWorldwide experience of 5000 patients reached

Manufacturer: Bolton Medical España, S.L.U.c\ Newton 18-24, 08635 – Sant Esteve Sesrovires, Barcelona, Spain +34.93.813.63.23U.S. Headquarters. Bolton Medical Inc. 799 International Parkway, Sunrise, FL 33325, +1.954.838.9699

RELAY PLUS - Caution: Investigational device. Limited by U.S. law to investigational use. RELAY NBS PLUS: Not for sale in the U.S.

Bolton Medical envisions to become a reference in the endovascular treatment of the entire aorta

2005

RELAYThoracic

Stent-GraftCE Mark

2006

BoltonMedical

Custom MadeProgram

RELAY Thoracic Stent-Graft FDA

Phase I Trial Completion

2009

RELAY PLUSThoracic Stent-Graft CE

Mark Approval

2000 Patients treated with theRELAY Thoracic

Stent-Graft Brand

RELAY NBSThoracic Stent-Graft

Halfway point in the U.S. Phase II clinical trial

2010

RELAY NBS PLUS Thoracic Stent-Graft CE Mark Approval

RELAY Thoracic Stent-Graft

FDA Phase II Trial Completion

3000 Patients treated with the RELAY Thoracic

Stent-Graft Brand

2008RELAY NBS

Thoracic Stent-Graft

CE Mark

2007

RELAY Thoracic Stent-Graft

250 mm lengthlowest number of stent-graftper patient

within TEVAR

2011

TREOVANCEAbdominal Stent-Graft

ADVANCE CE Mark Approval

Study completion

First-in Human RELAY Branched

Thoracic Stent-Graft

5000 patients treated with the RELAY

Thoracic Stent-Graft Brand

2012TREOVANCEAbdominalStent-Graft

CE Mark

BranchedStent-Graft

projectdevelopment

acknowledgments

oRGanIZaTIon: divine [id] agency Vérane Bergeron Moreau & Christine Arzouyan Tél . +33 (0) 491 57 19 60 Fax +33 (0) 491 57 19 61 carzouyan@divine-id .com www.divine-id.com

crit

ical

issu

es 2

012

- lil

le -

fran

ce

2012May 24 & 25lille - france

w w w . c r i t i c a l - i s s u e s - c o n g r e s s . c o m